Shreefal Mehta
Mathematics graduate from University of Texas at Austin, with MSc from Rutgers University, PhD from University of Texas Southwestern Medical Center and MBA from Rensselaer Polytechnic Institute. Founding CEO at The Paper Battery Company, Inc.
| Headline: | Entrepreneur |
| Website: | http://www.shreefalmehta.com |
| Skills: | Business, Engineering, Entrepreneurship, Management |
| Groups: | Ignite Clean Energy (ICE) |
| Interested in: | Advising startups, Brainstorming, Finding business partners, Finding cofounders, Finding engineers, Finding team mates, Giving back, Helping friends, Mentoring, Participating in a competition, Professional opportunities, Promoting my startups, Recruiting for my startup |
| Schools: | Rensselaer Polytechnic Institute, Rutgers University - New Brunswick, University of Texas System - Austin, University of Texas System - Southwestern Medical Center at Dallas |
WORK EXPERIENCE
| Employer: | The Paper Battery Company Inc. |
| Position: | Founding CEO |
| Time period: | July 2008 - Present |
| Description: | Currently developing a venture founded on the invention of a new way to construct safe and flexible energy storage devices. |
| Employer: | Rensselaer Polytechnic Institute |
| Position: | Teaching experience |
| Time period: | December 2007 - Present |
| Description: | Executive‐in‐Residence, Severino Center for Technological Entrepreneurship
Adjunct Associate Professor, Biomedical Engineering Department Executive Director, Radical Innovation Research Program 2003‐2005 Consulting with senior executives in market‐leading Fortune 500 companies (Intel, P&G, HP, Xerox, Rohm Haas, PPG, Dow Corning, Guidant, etc) and worked with a team of management faculty on the development and functioning of sustainable breakthrough innovation capabilities in large multinational corporations. Clinical Associate Professor of Biotechnology Management and Biomedical Engineering 2006 – 2008 (part time) Research Assistant Professor of Biotechnology Management and Biomedical Engineering 2001 – 2006 (part time) • Founded new interdisciplinary course on “Commercializing biomedical technologies” for graduate students from science, engineering and management schools. • Led a team that prepared a series of technology roadmaps for economic development planning • Quoted in Economist, Drug Discovery, Scientist and published in Nature Biotechnology and other leading industry journals on biotechnology commercialization. |
| Employer: | Cytopia (ASX:CYT) |
| Position: | Vice President, Business and Corporate Development |
| Time period: | December 2004 - July 2008 |
| Description: | Managed US operations (including scientific and corporate affairs), part of leadership team for strategic drug discovery portfolio planning, led global business development strategy; negotiated and partnered projects with multinational pharma companies, and established clinical and scientific partnerships. Cytopia has an ongoing partnership with Novartis (largest biotech deal in Australia to date), a commercial partnership (royalty earning) with Chemicon and an innovative risk‐sharing partnership with Cancer Therapeutics Ltd, Australia. |
| Employer: | Myomatrix Therapeutics |
| Position: | Co‐founder and CEO |
| Time period: | December 2000 - November 2004 |
| Description: | Grew cardiovascular pharmaceutical startup from concept to product development projects in heart failure, hypertension, ischemia/reperfusion and orphan diseases. The company was acquired by an Australian public biotech‐Cytopia. |
| Employer: | X‐Ray Optical Systems – Albany, NY |
| Position: | Technology Commercialization Consultant |
| Time period: | December 2000 - November 2002 |
| Description: | Developed market plan and strategy for successful launch of a new breakthrough technology (Dec 2001) into the petrochemical industry (online X‐ray sulfur analysis) with current annual revenues in the millions of dollars.
Worked in a team with CEO and Director of Marketing. |
| Employer: | University of Texas Southwestern Medical Center – Dallas, TX |
| Position: | Assistant Professor, Department of Radiology |
| Time period: | December 1994 - November 2000 |
| Description: | • Designed and developed a novel ultrasonic device for clinical applications–from concept to clinic to imaging device.
• Scientific activity in biomechanics, non‐destructive testing: and ultrasound imaging, molecular biophysics, tissue engineering. |
EDUCATION
| University: | Rensselaer Polytechnic Institute |
| Time period: | 2002 |
| Degree: | Technological entrepreneurship and innovation management, MBA |
| University: | University of Texas System - Southwestern Medical Center at Dallas |
| Time period: | 1995 |
| Degree: | Biomedical Engineering, PhD |
| University: | Rutgers University - New Brunswick |
| Time period: | 1993 |
| Degree: | Biomedical Engineering, MSc |
| University: | University of Texas System - Austin |
| Time period: | 1990 |
| Degree: | Mathematics, BSc |
PUBLICATIONS
| Papers: | Published peer‐reviewed papers in leading international journals, book chapters and books. |
| Books: | Mehta, S. ‐ Commercializing Successful Biomedical Technologies: Basic Principles for the Development of Drugs, Diagnostics and Device; Cambridge University Press, 2008.
http://www.commercializingbiotech.com. |
INFORMATION
| Memberships: | Member of steering committee of regional biotechnology industry alliance – www.bioconnex.org. |
| Awards: | 2006 – “40 Under 40” Award for rising business leaders in NY (Capital Region Business Review Annual Awards). |
Shreefal's Startups (1)
View all-
The Paper Battery Company
The first product of a game-changing energy storage device technology platform, licensed from Rensselaer (RPI), is a conformable, high energy density supercapacitor that is an architecturally integrated component, enabling new product innovation.